Artrya (ASX:AYA) said its US customer, Tanner Health, has started the commercial use of the Salix cloud platform for the assessment and management of coronary artery disease, generating the first fee per scan revenues for the company, according to a Friday Australian bourse filing.
Tanner Health used Salix's coronary plaque module at its Georgia hospital and will roll out the module to additional hospitals in the near term, the filing said. It can seek a $950 reimbursement for each assessment using the module, the filing added.
Shares of the company rose past 4% in recent Friday trade and earlier hit an all-time high.